Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration

Front Pediatr. 2023 Aug 21:11:1275389. doi: 10.3389/fped.2023.1275389. eCollection 2023.

¹ Department of Pharmacy, Texas Children's Hospital, Houston, TX, United States.
² Department of Pediatrics, Division of Critical Care and Pulmonology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States.
³ Department of Pediatrics, Division of Pulmonology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States.
⁴ Department of Pediatrics, Division of Critical Care, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States.
⁵ Department of Pulmonary Medicine, Texas Children's Hospital, Houston, TX, United States.

Abstract

[This corrects the article DOI: 10.3389/fped.2023.1050508.].

Keywords: initiation; pediatric pulmonary hypertension; prostacyclin; selexipag; transition; treprostinil.